Much progress has been made on blood-based biomarkers for neurological diseases, though challenges in this field should be addressed before they are applied into clinical use.
Browsing: Cognitive/neurodegenerative disorders
According to a recently published survey from Alzheimer’s Research UK, half of UK adults can’t identify a single key risk factor for dementia.
In this review article from Biomarkers in Medicine, researchers explore the current application of blood-based markers to assess amyloid-β pathology.
Researchers have indicated that gingipain inhibitors may be used in treating periodontal disease and neurodegeneration in Alzheimer’s.
Researchers have identified a simple blood test that may be able to diagnose neurodegeneration before symptoms arise; this could lead to earlier diagnosis of Alzheimer’s disease.
We had the pleasure of filming a joint seminar from the Michael J Fox Foundation and Abcam on biomarkers of neuroinflammation in Parkinson’s disease. Discover more about this in our video, with timepoints for each slide included.
A new imaging study will be the first to use the GE180 ligand tracer to detect neuroinflammation in Parkinson’s and Alzheimer’s disease brains.
An experimental drug being developed for the treatment of stroke may also prevent Alzheimer’s by preventing the build-up of toxic proteins.
In this video, Marc Goldfinger provides us with an overview of his work on CTE and boxer’s brains, including why CTE is of increasing public interest.